When will the Smith & Nephew dividend start growing again?

The Smith & Nephew dividend yield has caught our writer’s eye as he considers adding the shares to his portfolio. But could it get higher in future?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Female Doctor In White Coat Having Meeting With Woman Patient In Office

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Medical devices manufacturer Smith & Nephew (LSE: SN) currently boasts a dividend yield of 3.2%. While that does not put it among the top ranks of FTSE 100 dividend payers, the yield is still attractive to me. But after previously rising most years for over a decade, the Smith & Nephew dividend has been static since the pandemic began. Might that change any time soon?

Flat interim dividend

In July, the company announced an interim dividend of 14.4c per share. On the one hand that was not surprising. After all, it was in line with Smith & Nephew’s stated policy of aiming to pay out an interim dividend equal to 40% of its most recent full-year dividend.

On the other hand, though, the news that the interim dividend would be the same for the fourth year in a row was a little disappointing. Prior to the pandemic, the company regularly raised its annual dividend. It rarely held its interim payout flat, while boosting the final one, meaning the overall annual amount rose. That last happened in 2017. Apart from that, it had raised its interim dividend every year this century before 2020. Since then, it has held both it and the final one flat.

Might the dividend rise this year?

That does not mean that this year’s full dividend will be flat. Although it did not increase the interim payout, the company could still choose to boost the final payout – just as it did back in 2017.

Will this happen? Nobody knows. After all, having held the dividend flat for the past few years, management could decide to do the same again. Such payouts are never guaranteed.

It is not that the company lacks money to increase it. In the first half, its earnings per share more than covered the payout.

Smith & Nephew did not give any specific indication of its intention for the full-year dividend in the interim results. But it did mention a capital allocation policy it adopted last year, including making reference to “our existing progressive dividend policy”.

A progressive dividend policy is one in which a company aims to raise its total payout each year. The results mentioning such a policy makes me think that the annual one may grow this year. That would happen if the company increases the size of its final payout.

My move

Whether that turns out to be the case will become clear when the company publishes its final results, probably in February.

I see Smith & Nephew as a blue-chip company with a quality business. Demand for the sorts of medical devices it produces will likely remain high. As quality matters for its customers, the company has pricing power. The Smith & Nephew dividend yield is attractive to me already. Any increase would only make it more so.

I do still see risks. Recovery from the pandemic has been slow, and inflation threatens to eat into profit margins. But I like the business and would consider buying the shares for my portfolio. If I do that now, hopefully I can benefit if the company starts increasing its annual dividend again.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

C Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Smith & Nephew. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

Will the BP share price go gangbusters under President Trump?

The BP share price has had a rough ride lately and Harvey Jones says the FTSE 100 oil giant looks…

Read more »

Satellite on planet background
Investing Articles

Is this the best bargain in the FTSE 250 right now?

This FTSE 250 defence stock is a world leader in testing and evaluation technology for military use and has seen…

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

How would I start planning my Stocks and Shares ISA for 2025? With this super-solid growth stock

I can’t think of a better way to prepare for a new year than opening a fresh Stock and Shares…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Down 26% to just £4, Glencore’s share price looks cheap to me right now

Market pessimism over China’s economic growth has helped push Glencore’s share price down but I think this is overdone, leaving…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in November [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Why now could be the time to get ready for a stock market crash

Both the FTSE 100 and the S&P 500 climbed after the US election results. But Stephen Wright thinks now is…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

A UK share and an ETF that could soar following Trump’s election win

Donald Trump's White House return poses huge uncertainty for the global economy. But this UK share and ETF could gain…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

2 FTSE stocks that demonstrate the best (and worst) of the AIM market

Our writer looks at the performance of two very different FTSE stocks that highlights the pros and cons of investing…

Read more »